This European Commission Submitted a Claim Against pharmaceutical companies AstraZeneca Failed to fulfill its commitment to deliver the contracted dose of vaccine against COVID-19 to Member States.
“The European Commission has begun on Friday Legal proceedings against AstraZeneca Breach of the pre-purchase agreement“, Stefan de Keersmaecker, the health spokesperson of the community chief executive, announced at a press conference.
“Certain terms of the contract were not complied with, the company Does not provide a reliable strategy The spokesperson pointed out that “to ensure proper dose distribution”, he appointed Brussels to “act” in his own name and to act on behalf of “27 member states”, which is fully in line with “this decision.”
For community leaders, the most important Within the framework of this procedure is to obtain an Anglo-Swedish laboratory Distribute “fast” To EU countries Committed dose According to the contract between the two parties.
This Anglo-Swiss pharmaceutical company assured its customers this Monday “Complied fully” A vaccine sales agreement against covid-19 was reached with the European Commission, so it will be “strongly defended” in court.
“AstraZeneca has fully complied with the “Pre-purchase Agreement” reached with the European Commission, and will defend itself vigorously in court. We believe that any litigation is unfounded. We welcome the opportunity to resolve this dispute as soon as possible.“The company said in a statement.
The European Commission already knows that it is negotiating with member states to bring the dispute with AstraZeneca to justice. Only 29.8 million vaccines were provided in the first quarter Compared with the 300 million doses promised in the second time, it is estimated that only 70 million doses will be provided in the second second.
In her note, the pharmacist assured that she would arrive Before the end of April, nearly 50 million doses were distributed to EU countries, “Consistent with our prediction-he added.”
AstraZeneca recognizes that “the work done by political leaders and medical professionals in all member states makes it possible to carry out vaccination campaigns in Europe” and ensure They are “committed to providing as much help as possible”.
The company recalls vaccines “They are difficult to make, The supply challenges faced by many companies in Europe and around the world testify to this. “
It also emphasized that although they are “making progress in solving the technical challenges they face, and their production is improving, despite “The vaccine production cycle is very long, This means that it will take some time for these improvements to lead to increased doses of finished vaccines. “
“As we continue to respond to the terrible pandemic and the distribution of vaccination plans, there is still a lot of work to be done in the European Union (EU) and elsewhere. AstraZeneca plays an important role, and our goal remains to do it fairly. It also clarified the fairness of no benefit during the pandemic in the EU and the world.”
The communiqué also recalled that the EU has supported COVAX program Aimed at the fair distribution of vaccines to low- and middle-income countries, the Anglo-Swiss company is a leading provider in more than 100 countries.
AstraZeneca also expressed its hope to “constructively cooperate with the European Commission to vaccinate as many people as possible.” “Thousands of our employees who work 24/7 have received an unprofitable enthusiasm for helping the world.; Continue to be firmly committed to providing our vaccines to people in Europe and around the world“, the company said.